Navigation

Artificial alternative to an important natural substance

 

We are looking for an alternative to the important natural antibiotic colistin. With this in mind we are systematically exploring related structures by chemically synthesising those that do not occur naturally.

Portrait / project description (ongoing research project)

When nothing else works, maybe colistin will. Nowadays this antimicrobial peptide of natural origin is used as the last resort against many multiresistant germs. Yet it can have considerable side effects, and there are now bacteria that are resistant to it. Other peptides offer particular promise in the search for alternatives to this important substance. We have already discovered some that are active against multiresistant bacteria by systematically investigating peptides related to colistin that do not occur naturally. They have never been studied before because they are not natural substances. We are now optimising these artificial peptides, investigating their mechanism of action and assessing which might be useful for medical purposes.

Background

We are using the chemical space approach. This term refers to the total number of existing molecules that can be used as medicines. Nowadays the chemical space can be explored efficiently using bioinformatic methods and automated chemical synthesis, and this is being done in many laboratories. We have expanded this approach to include new molecules that are not found in nature and which have therefore not been studied previously.

Aim

Our goal is to identify previously unknown peptides whose antibiotic action and favourable pharmacological profile may potentially make them suitable for use in human medicine. The intention is to put these peptides into clinical development.

Relevance

New antibiotics are important for public health. One particular advantage of our peptides is that they are easy to synthesise and can therefore be optimised. They are also easy to patent because they are chemically unique, which makes them a very interesting proposition for clinical development.

Original title

Antimicrobial peptide dendrimers (AMPD) and bicyclic peptides (AMBP) as therapeutic agents against multidrug resistant bacteria

Project leaders

  • Prof. Jean-Louis Reymond, Departement für Chemie und Biochemie, Universität Bern, Bern
  • Professeur Christian Van Delden, Hôpitaux Universitaires de Genève, Département des spécilaités de médecine, Genève

 

 

Further information on this content

 Contact

/SiteCollectionImages/portraetbilder/Reymond-Jean-Louis_0007.jpg

Prof. Jean-Louis Reymond Departement für Chemie und Biochemie Universität Bern Freiestrasse 3 3012 Bern +41 31 631 43 11 jean-louis.reymond@ioc.unibe.ch